M2care secures €26 million from the FTA2 fund managed by BPI France
Healthtech venture studio M2care raises €26 million to accelerate the creation and development of innovative healthcare projects Paris, 03 September 2025 – M2care,
26 August 2025
Rhovica secures CHF 2.3M and nominates Carsten Laue as Board Member
Rhovica Neuroimaging secures CHF 2.3M (EUR 2.5M) financing led by M2care to accelerate development of SoNav™ neurosurgical device Bern, Switzerland and Lyon, France, 26
21 February 2025
SEPSI Score: promising results from the retrospective study
M2care is proud to announce the closing of its first financing round of €20 million. This round of financing is being carried out in
10 December 2024
Inserm Transfert and M2care sign partnership agreement
Inserm Transfert, a subsidiary of Inserm dedicated to technology transfer, and M2care are partnering to support the development of innovative start-ups emerging from Inserm
2 December 2024
Collaboration between Rhovica Neuroimaging and M2care for the Advancement of Neurosurgery
Rhovica Neuroimaging was founded in Bern, Switzerland, in 2023 by Martin Hlavica and Thomas Rhomberg, two talented neurosurgeons. Their ambition is to improve the
